Factors influencing the ablative efficiency of high intensity focused ultrasound (HIFU) treatment for adenomyosis: A retrospective study
This study analyzed 245 adenomyosis patients, finding that lesion characteristics, uterine and lesion location, and patient abdominal wall thickness predict high intensity focused ultrasound ablative efficiency.
One-sentence paraphrase of the abstract; not a substitute for reading it. No clinical advice. How this works
Abstract
My notes (saved in your browser only)
Condition tags
MeSH descriptors
Citation neighborhood
Papers in the corpus that this work cites (lower rings, blue) and that cite this one (upper rings, green). Dot size scales with the paper's in-corpus citation count — bigger dot = more influential within the endo/adeno field. Click a dot to open that paper. [ expand to 2 hops ] — adds papers reached through this work's immediate citers/citees. Heavier; up to 60 extra dots.
References (20)
- Adenomyosis: a neglected diagnosis. via openalex
- Diffuse adenomyosis: comparison of endovaginal US and MR imaging with histopathologic correlation. via openalex
- Effective ablation therapy of adenomyosis with ultrasound‐guided high‐intensity focused ultrasound via openalex
- Effects of oxytocin on high intensity focused ultrasound (HIFU) ablation of adenomysis: A prospective study via openalex
- Feasibility of laparoscopic high-intensity focused ultrasound treatment for patients with uterine localized adenomyosis via openalex
- Imaging features of adenomyosis via openalex
- Pathologic Findings from the Maryland Womenʼs Health Study: Practice Patterns in the Diagnosis of Adenomyosis via openalex
- Safety and Efficacy of High Intensity Focused Ultrasound Ablation Therapy for Adenomyosis via openalex
- Surgical and medical treatment of adenomyosis via openalex
- The elusive adenomyosis of the uterus—revisited via openalex
- Ultrasound-guided high-intensity focused ultrasound ablation for adenomyosis: the clinical experience of a single center via openalex
- Ultrasound-guided high-intensity focused ultrasound (USgHIFU) ablation for the treatment of patients with adenomyosis and prior abdominal surgical scars: A retrospective study via openalex
- W2766403853 via openalex
- W1967197865 via openalex
- W1981755049 via openalex
- W2026769272 via openalex
- W2087831276 via openalex
- W2103284425 via openalex
- W2104825245 via openalex
- W2410786902 via openalex
Cited by (30)
- Prediction of clinical outcome for high-intensity focused ultrasound ablation of adenomyosis based on non-enhanced MRI radiomics 2025
- Non-surgical Treatment of Adenomyosis 2024
- High-intensity focused ultrasound in adenomyosis treatment: Insights on safety, efficacy, and reproductive prospects 2024
- Non-contrast enhanced MRI for efficiency evaluation of high-intensity focused ultrasound in adenomyosis ablation 2024
- High-intensity focused ultrasound for endometrial ablation in adenomyosis: a clinical study 2024
- High-intensity focused ultrasound for endometrial ablation in adenomyosis: A clinical study 2023
- Transvaginal ultrasound- and laparoscopy-guided percutaneous microwave ablation for adenomyosis has short- and long-term benefits: a single-center study 2023
- Efficacy and safety of percutaneous microwave ablation for adenomyosis in the posterior uterine wall 2023
- Comparison of the treatment efficacies of HIFU, HIFU combined with GnRH-a, and HIFU combined with GnRH-a and LNG-IUS for adenomyosis: A systematic review and meta-analysis 2023
- Current Trends of Alternatives to Hysterectomy in Adenomyosis: A Review Article 2023
- Doppler Imaging Assessment of Changes of Blood Flow in Adenomyosis After Higher‐Dose Oxytocin: A Randomized Controlled Trial 2022
- Classifications of Adenomyosis and Correlation of Phenotypes in Imaging and Histopathology to Clinical Outcomes: a Review 2022
- Image-guided thermal ablation in the management of symptomatic adenomyosis: a systematic review and meta-analysis 2021
- Magnetic resonance imaging T2WI hyperintense foci number and the prognosis of adenomyosis after high‐intensity focused ultrasound treatment 2021
- Objective measures of adenomyosis on MRI and their diagnostic accuracy—a systematic review & meta‐analysis 2021
- Microbubble contrast agent SonoVue combined with oxytocin improves the efficiency of high-intensity focused ultrasound ablation for adenomyosis 2021
- Adenomyosis and HIFU Ablation 2021
- Transvaginal ultrasound- and laparoscopy-guided percutaneous microwave ablation for adenomyosis: preliminary results 2019
- Classification and Reporting Systems for Adenomyosis 2019
- Influences of screening magnetic resonance imaging parameters on high-intensity focused ultrasound outcome for adenomyosis 2018
- Comparison of effectiveness of epidural analgesia and monitored anesthesia care for high-intensity focused ultrasound treatment of adenomyosis 2018
- Magnetic resonance imaging features influencing high-intensity focused ultrasound ablation of adenomyosis with a nonperfused volume ratio of ≥90% as a measure of clinical treatment success: retrospective multivariate analysis 2018
- Effect of pre-treatment with gonadotropin-releasing hormone analogue GnRH-α on high-intensity focussed ultrasound ablation for diffuse adenomyosis: a preliminary study 2018
- Minimally invasive treatment of adenomyosis 2018
- Clinical Usefulness of the Microbubble Contrast Agent SonoVue in Enhancing the Effects of High‐Intensity Focused Ultrasound for the Treatment of Adenomyosis 2018
- The role of T1 perfusion-based classification in predicting the outcome of magnetic resonance-guided high-intensity focused ultrasound treatment of adenomyosis 2017
- High intensity focused ultrasound for the treatment of adenomyosis: selection criteria, efficacy, safety and fertility 2017
- Percutaneous microwave ablation with artificial ascites for symptomatic uterine adenomyosis: initial experience 2017
- Treatment options and reproductive outcome for adenomyosis-associated infertility 2017
- Ultrasound-guided transcervical radiofrequency ablation for symptomatic uterine adenomyosis 2016
Source provenance
- europepmc
- last seen: 2026-06-04T01:30:01.192114+00:00
- openalex
- last seen: 2026-06-04T00:00:01.174412+00:00
- pubmed
- last seen: 2026-05-13T22:21:00.404924+00:00